2024-05-15T10:01:19-05:00 2023-06-30 390859910 BAKER TILLY US LLP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2022-10-01 260791997 KENTUCKY HEART FOUNDATION INC KENT 6063241544 2201 LEXINGTON AVENUE ASHLAND KY 41101 AUTUMN MCFANN TREASURER, SR VP/CFO/CAO 6063241544 2024-05-13 1 AUTUMN MCFANN 999009999 1 KERRI N BOGDA CPA P00760402 7177404863 2024-05-13 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z SARA MARKS 2201 LEXINGTON AVENUE ASHLAND KY 41101 660 0 X N/A X 2007 KY TO REDUCE THE IMPACT OF HEART AND VASCULAR DISEASE THROUGH RESEARCH, PREVENTION, AND EDUCATION. 10 10 0 13 0 0 680 375 0 0 119 285 0 0 799 660 0 0 0 0 100134 58121 0 0 0 6211 4247 106345 62368 -105546 -61708 569146 569431 0 1057 569146 568374 X TO REDUCE THE IMPACT OF HEART AND VASCULAR DISEASE THROUGH RESEARCH, PREVENTION, AND EDUCATION. VISION: TO IMPROVE THE QUALITY OF LIFE BY REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE. 0 0 62368 THE KENTUCKY HEART FOUNDATION (KHF) WAS FOUNDED IN MAY 2007. THE KHF IS A NONPROFIT ORGANIZATION THAT WORKS WITH OTHER HEALTHCARE PROVIDERS TO ADDRESS HEART AND VASCULAR DISEASE IN THIS REGION. IN CONJUNCTION WITH THESE OTHER PROVIDERS THE KHF WORKS ON THE FOLLOWING: IMPROVING THE QUALITY OF LIFE IN THE APPALACHIAN REGION REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE ADVANCING MEDICAL SCIENCE THROUGH INTEGRATED, INNOVATIVE AND PROGRESSIVE PROGRAMS IN RESEARCH, EDUCATION, PREVENTION, EARLY DETECTION, AND IMPROVED PATIENT CARE CREATING ACCESS TO CUTTING-EDGE TECHNOLOGY DEVELOPING A FORUM FOR RESEARCH THAT WILL BENEFIT PATIENTS THROUGHOUT THE NATIONKHF'S VISION IS TO IMPROVE THE QUALITY OF LIFE BY REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE. OUR MISSION IS TO REDUCE THE IMPACT OF HEART AND VASCULAR DISEASE THROUGH RESEARCH, PREVENTION AND EDUCATION. PRIORITIES INCLUDE: RESEARCH, EDUCATION, PREVENTION, FINANCE, AND CULTURE.THE KHF SERVES APPALACHIAN COUNTIES COVERING PARTS OF EASTERN KENTUCKY, SOUTHEASTERN OHIO AND WESTERN WEST VIRGINIA. THESE COUNTIES ARE SOME OF THE MOST IMPOVERISHED IN THE AREA. ALSO KNOWN AS THE CORONARY VALLEY, THE AREA GOT THIS NAME BECAUSE OF THE HIGH MORTALITY RATES FROM CARDIOVASCULAR DISEASE AND THE POOR HEALTH HABITS OF ITS RESIDENTS. HEART DISEASE IS THE NUMBER ONE KILLER OF ADULTS, WITH MORTALITY RATES VERY HIGH COMPARED TO STATE AND NATIONAL DATA. RESIDENTS OF THE AREA HAVE LOW ACADEMIC ACHIEVEMENT; HIGH SMOKING RATES; LACK OF PHYSICAL EXERCISE; AND ONE OF THE HIGHEST OBESITY RATES IN THE NATION. ALL COMBINED, IT IS NO WONDER THAT CARDIOVASCULAR DISEASE IS THE NUMBER ONE HEALTH THREAT FOR ADULTS IN THE AREA. WITH A FOCUS ON IMPROVING THE CARDIOVASCULAR OUTCOMES FOR THE AREA'S RESIDENTS. PARTNERING WITH PROGRESSIVE CARDIOLOGISTS, CARDIOTHORACIC SURGEONS, VASCULAR SURGEONS, AND INTERVENTIONAL RADIOLOGISTS AT KING'S DAUGHTERS PROVIDES THE KHF THE OPPORTUNITY TO ANSWER IMPORTANT CLINICAL RESEARCH QUESTIONS IN ORDER TO IMPROVE CARE FOR OUR PATIENTS FOR NOW AND GENERATIONS TO COME.THE KHF WORKS WITH DEVICE AND DRUG MANUFACTURERS TO BRING NEW RESEARCH PROGRAMS TO THE REGION. KHF HAS BEEN AND CONTINUES TO BE FOCUSED ON RESEARCH TO IMPROVE THE ASSESSMENT, PREVENTION, AND TREATMENT OF ACUTE CORONARY SYNDROME, MYOCARDIAL INFARCTION, DUAL ANTIPLATELET THERAPY, ATRIAL FIBRILLATION, HEART FAILURE, STROKE AND VASCULAR DISEASE, CHILDHOOD AND ADULT OBESITY, AND LUNG HEALTH.THE KHF HAS THREE PRIMARY PROGRAM-RELATED FOCUSED AREAS: RESEARCH, EDUCATION, AND PREVENTION. 1) RESEARCH: DURING FY2023, THE KHF CONTINUED TO FOCUS ON RESEARCH FOLLOWING UP TO 25 PATIENTS IN ACTIVE CLINICAL TRIALS, INCLUDING:- IN.PACT AV ACCESS STUDY: RANDOMIZED STUDY OF IN.PACT AV ACCESS PACLITAXEL-COATED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON VS. STANDARD PTA FOR THE TREATMENT OF OBSTRUCTIVE LESIONS IN THE NATIVE ARTERIOVENOUS DIALYSIS FISTULAE (AVF)- RANGER II SFA: A 3:1 RANDOMIZED TRIAL COMPARING THE BOSTON SCIENTIFIC RANGER PACLITAXEL COATED BALLOON VS. STANDARD BALLOON ANGIOPLASTY FOR THE TREATMENT OF SUPERFICIAL FEMORAL ARTERIES (SFA) AND PROXIMAL POPLITEAL ARTERIES (PPA).- WAVE: PROSPECTIVE, RANDOMIZED, CONTROLLED, MULTICENTER STUDY COMPARING THE MERIT WRAPSODY ENDOVASCULAR STENT GRAFT TO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TREATMENT OF VENOUS OUTFLOW CIRCUIT STENOSIS OR OCCLUSION IN HEMODIALYSIS PATIENTS.THE FOUNDATION CONTINUALLY LOOKS FOR TRIALS AND STUDIES THAT WILL BE OF BENEFIT TO OUR PATIENTS AND OUR PHYSICIANS. 2) EDUCATION: THE KHF OFFERS BOTH HEALTHCARE PROVIDER AND COMMUNITY EDUCATION AS PART OF ITS SCOPE OF WORK. DURING FY2023, THE KHF HOSTED CONTINUING MEDICAL EDUCATION: THE KHF IS ACCREDITED BY THE KENTUCKY MEDICAL ASSOCIATION TO PROVIDE CONTINUING MEDICAL EDUCATION, PROVIDING EDUCATIONAL PROGRAMMING FOR PHYSICIANS AFFILIATED WITH KING'S DAUGHTERS MEDICAL CENTER. DURING THE YEAR, CONTINUING MEDICAL EDUCATION PROGRAMS AND REGULAR SCHEDULED SERIES WERE HOSTED WHILE NUMEROUS OTHER DISCIPLINES (NURSE PRACTITIONERS, NURSES, PHYSICAL THERAPISTS, PHYSICIAN ASSISTANTS, ETC.) ALSO TOOK ADVANTAGE OF CME PROGRAMS.3) PREVENTION: IN PARTNERSHIP WITH KING'S DAUGHTERS COMMUNITY HEALTH TEAM, WE FOCUS ON EARLY DETECTION OF CARDIOVASCULAR RISK FACTORS AND PROPER TREATMENT ARE CRITICAL TO REDUCING THE DEVASTATING IMPACT OF CARDIOVASCULAR DISEASE. PROGRAMS AND SCREENINGS INCLUDE FREE HEALTHY HEART SCREENINGS, LOW COST HEART AND VASCULAR SCREENINGS AND LOW COST BLOOD PROFILES THROUGHOUT THE REGION. THIS OUTREACH EFFORT HELPED COMMUNITY MEMBERS UNDERSTAND THEIR PERSONAL RISKS OF HEART DISEASE AND PROVIDED LOW-COST, EASY ACCESS TO REGULAR BLOOD WORK TO MONITOR BLOOD SUGAR, CHOLESTEROL AND OTHER KEY METABOLIC MEASURES. 62368 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 KY X LAURIE STEWART CONTROLLER 6064089640 2201 LEXINGTON AVENUE ASHLAND KY 41101 DAVID JONES CHAIRMAN 0.25 6.25 X X 0 0 0 DR MARK NEWMAN BOARD VICE-CHAIRMAN (UNTIL 12/31/22) 0.25 5.75 X X 0 0 0 STEPHEN ADDINGTON DIRECTOR 0.25 2.50 X 0 0 0 MARK BIRDWHISTELL DIRECTOR 0.25 2.25 X 0 0 0 TOM BURNETTE DIRECTOR 0.25 2.75 X 0 0 0 CRAIG COLLINS DIRECTOR 0.25 2.25 X 0 0 0 ERIC MONDAY DIRECTOR 0.25 2.25 X 0 0 0 JOHN STEWART DIRECTOR 0.25 2.75 X 0 0 0 PENNY COX DIRECTOR 0.25 2.25 X 0 0 0 GINA DUGAS DIRECTOR 0.25 2.25 X 0 0 0 ROBERT DIPAOLA DIRECTOR 0.25 2.25 X 0 0 0 SHERYL MAHANEY UNTIL 113022 SECRETARY, VP/CHIEF LEGAL OFFICER 1.25 60.75 X 0 1518132 8395 AUTUMN MCFANN TREASURER, SR VP/CFO/CAO 1.25 60.25 X 0 1897128 131808 SARA MARKS PRESIDENT/CEO (BEG. 1/1/23) 1.25 60.25 X 0 1844834 142949 AMY SAUNDERS ASSISTANT SECRETARY (STARTING 12/1/22) 0.25 45.75 X 0 227968 12371 KRISTIE WHITLATCH PRESIDENT/CEO (10/1/22-12/31/22) 1.25 60.75 X 0 0 0 STEVEN CLIFTON SECRETARY (STARTING 12/1/22) 0.25 5.75 X 0 0 0 CHARBEL SALEM MD MEDICAL DIRECTOR 10.00 40.25 X 0 782130 94176 PATRICIA CORBITT EXECUTIVE DIRECTOR 2.00 40.00 X 0 185439 32109 0 6455631 421808 0 0 1 0 0 375 375 285 285 660 0 0 285 44709 44709 13412 13412 449 449 PROGRAM SUPPORT 3753 3753 OTHER 45 45 62368 62368 0 0 569146 569431 569146 569431 1057 0 1057 X 569146 568374 569146 568374 569146 569431 X -61708 60936 X 0 1 X 1 0 X 78058 14486 4418 680 375 98017 78058 14486 4418 680 375 98017 47412 50605 4675 3308 260 119 285 8647 106664 0.47440 0.34510 X SCHEDULE A, PAGE 3, PART III KENTUCKY HEART FOUNDATION, INC. FILED A SHORT YEAR RETURN FOR FISCAL YEAR END JUNE 30, 2023. 0 0 0 0 0 0 0 0 1 449 449 0 PART II-B, LINE 1: A PORTION OF THE DUES PAID TO THE KENTUCKY MEDICAL ASSOCIATION ARE ATTRIBUTABLE TO LOBBYING. FOR THE YEAR ENDED 6/30/23, THE AMOUNT WAS $449. 1 1 1 0 0 0 0 0 1 0 AUTUMN MCFANN TREASURER, SR VP/CFO/CAO 0 480101 0 138000 0 1279027 0 113725 0 18083 0 2028936 0 50000 SARA MARKS PRESIDENT/CEO (BEG. 1/1/23) 0 464919 0 133500 0 1246415 0 113725 0 29224 0 1987783 0 50000 SHERYL MAHANEY UNTIL 113022 SECRETARY, VP/CHIEF LEGAL OFFICER 0 307303 0 0 0 1210829 0 0 0 8395 0 1526527 0 0 CHARBEL SALEM MD MEDICAL DIRECTOR 0 781387 0 0 0 743 0 63725 0 30451 0 876306 0 0 AMY SAUNDERS ASSISTANT SECRETARY (STARTING 12/1/2 0 190304 0 37219 0 445 0 10268 0 2103 0 240339 0 0 PATRICIA CORBITT EXECUTIVE DIRECTOR 0 140338 0 16641 0 28460 0 11746 0 20363 0 217548 0 0 PART I, LINE 3 COMPENSATION FOR THE CEO IS DETERMINED BY ASHLAND HOSPITAL CORPORATION (RELATED ORGANIZATION) USING THE FOLLOWING METHODS: INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY/STUDY, AND APPROVAL BY THE BOARD/COMPENSATION COMMITTEE. PART I, LINES 4A-B THREE EMPLOYEES RECEIVED CHANGE IN CONTROL PAYMENTS: SHERYL MAHANEY $1,209,162 SARA MARKS $1,175,614 AUTUMN MCFANN $1,208,771 THESE WERE PAID AS A RESULT OF THE 12/1/22 MEMBER SUBSTITUTION WITH THE UNIVERSITY OF KENTUCKY. THE FOLLOWING INDIVIDUALS RECEIVED PAYMENTS FROM A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN: AUTUMN MCFANN $18,996 SARA MARKS $19,541. THE CEO AND CERTAIN VICE PRESIDENTS, WHOSE BENEFIT IN THE QUALIFIED TAX SHELTERED ANNUITY PLAN IS LIMITED DUE TO THE IRS COMPENSATION AND BENEFIT LIMITS, RECEIVE A BENEFIT RESTORATION CONTRIBUTION UNDER THE DEFERRED ANNUITY PLAN THAT IS PAID AS A TAXABLE DISTRIBUTION TO THE PARTICIPANT ANNUALLY. 4 EMPLOYEES RECEIVED 457(F) EXECUTIVE RETENTION PLAN PAYOUTS: AUTUMN MCFANN $50,000 SARA MARKS $50,000 ALL OF THESE PAYMENTS WERE MADE BY AHC. PART I, LINE 7 NONFIXED PAYMENTS ARE MADE AS A PART OF THE MEDICAL CENTER'S TEAM INCENTIVE AWARD (TIA) PLAN. ALL TEAM MEMBERS ARE ELIGIBLE FOR THE TIA. THE TIA IS PAID OUT BASED UPON SUCCESSFUL COMPLETION OF BOTH QUANTITATIVE AND QUALITATIVE STRATEGIC GOALS, SET ANNUALLY BY THE MEDICAL CENTER LEADERSHIP TEAM AND APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART V, LINE 2: THERE ARE NO EMPLOYEES OF KENTUCKY HEART FOUNDATION, INC. ("KHF"). SALARIES REPORTED ON PART IX LINE 7 REPRESENT THE ALLOCATED PAYROLL EXPENSE FOR THE TIME SPENT ON KHF BY ASHLAND HOSPITAL CORPORATION ("AHC") EMPLOYEES. KHF REIMBURSES AHC FOR THIS APPORTIONED TIME. ALL PAYROLL FILINGS ARE COMPLETED BY AHC UNDER EIN 61-0444716. AHC IS THE PARENT ORGANIZATION OF KHF. FORM 990, PART VI, SECTION A, LINE 6 ASHLAND HOSPITAL CORPORATION (AHC) IS THE SOLE CORPORATE MEMBER OF KENTUCKY HEART FOUNDATION, INC. (KHF). AHC, A 501(C)(3) ENTITY, IS THE PARENT ORGANIZATION OF AN INTEGRATED HEALTHCARE DELIVERY SYSTEM. FORM 990, PART VI, SECTION A, LINE 7A THE KHF BOARD IS FOLDED INTO THE MAIN BOARD OF TRUSTEES OF AHC'S PARENT CORPORATION. THE BUSINESS OF KHF IS AS AN AGENDA ITEM OF THE FULL BOARD INDEPENDENTLY OR THROUGH ITS COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE 990 WILL BE REVIEWED BY THE CFO AND CONTROLLER BEFORE IT IS FILED WITH THE IRS. THE 990 WILL BE KEPT ON FILE AND AVAILABLE FOR REVIEW BY BOARD MEMBERS UPON REQUEST. FORM 990, PART VI, SECTION B, LINE 12C ASHLAND HOSPITAL CORPORATION DBA KING'S DAUGHTERS MEDICAL CENTER, PARENT ORGANIZATION OF KENTUCKY HEART FOUNDATION (KHF), REQUIRES ALL DIRECTORS, OFFICERS, AND KEY EMPLOYEES TO COMPLY WITH ITS CONFLICTS OF INTEREST POLICY, WHICH TRACKS THE IRS' RECOMMENDED POLICY WITH RESPECT TO SUCH OFFICERS AND DIRECTORS. MEMBERS OF THE MEDICAL CENTER'S BOARD OF DIRECTORS MUST ANNUALLY IDENTIFY, IN WRITING, ANY INTEREST THAT COULD GIVE RISE TO A CONFLICT, SUCH AS A LEADERSHIP POSITION IN A CONFLICTING ORGANIZATION; DISCLOSURE IS NOT LIMITED TO FINANCIAL CONFLICTS. LEADERSHIP EMPLOYEES MUST ANNUALLY CERTIFY, IN WRITING, THAT THEY KNOW OUR CONFLICTS OF INTEREST POLICY AND PROCEDURE AND HAVE NO CONFLICTS OF INTEREST. IN ADDITION, EMPLOYEES OF THE MEDICAL CENTER CERTIFY THAT NO CONFLICTS OF INTEREST EXIST OR OBTAIN AN ADVANCE WAIVER OF ANY CONFLICTS. THE MEDICAL CENTER'S HUMAN RESOURCES AND CORPORATE COMPLIANCE DEPARTMENTS MAINTAIN ALL RELEVANT DISCLOSURES AND SIGNATURES. ALL EMPLOYEES PROVIDE ANNUAL CONFLICT CHECKS. IF A CONFLICT OF INTEREST IS REPORTED, THE VICE PRESIDENT TO WHOM THE REPORTING EMPLOYEE DIRECTLY OR INDIRECTLY REPORTS, TOGETHER WITH THE CEO, CORPORATE COMPLIANCE OFFICER AND GENERAL COUNSEL, DETERMINES IF A CONFLICT EXISTS. IF THE REPORTING EMPLOYEE IS A VICE PRESIDENT, THE CEO, IN CONSULTATION WITH THE GENERAL COUNSEL, DETERMINES IF A CONFLICT EXISTS. ANNUALLY, BOARD MEMBERS DISCLOSE PERSONAL AND PROFESSIONAL RELATIONSHIPS TO THE SECRETARY OF THE BOARD. IF A POTENTIAL CONFLICT EXISTS, THE BOARD SECRETARY OR A BOARD MEMBER WILL IDENTIFY THE CONFLICT, OR POTENTIAL CONFLICT, AND THE BOARD MEMBER WILL BE REMOVED FROM ANY PART OF THE DECISION-MAKING PROCESS, AND HAS NO ROLE IN THE INSTANCE IN WHICH THE CONFLICT EXISTS. A BOARD MEMBER WHO HAS A CONFLICT OF INTEREST MUST ABSTAIN FROM ANY RELEVANT DISCUSSION OR VOTE. IF A CONFLICT OF INTEREST IS DISCOVERED AFTER THE FACT, THE CEO AND VICE PRESIDENT, TOGETHER WITH THE GENERAL COUNSEL, IF APPROPRIATE, REVIEW THE INSTANCE IN WHICH THE CONFLICT OCCURRED. THOSE LEADERS DETERMINE WHETHER THE CONFLICTED INDIVIDUAL INFLUENCED THE DECISION-MAKING OR PROFITED FROM THE CONFLICT. THE CONFLICTED INDIVIDUAL IS REMOVED FROM ANY FURTHER INVOLVEMENT. IN ADDITION, ANY FAILURE TO REPORT CONFLICTS OF INTEREST VIOLATES THE MEDICAL CENTER'S POLICY AND COULD RESULT IN DISCIPLINARY ACTION, UP TO AND INCLUDING TERMINATION OF EMPLOYMENT OR REMOVAL FROM THE MEDICAL CENTER'S BOARD OF DIRECTORS. MEDICAL STAFF MEMBERS ARE REQUIRED BY THE MEDICAL STAFF BYLAWS TO DISCLOSE CONFLICTS OF INTEREST. ONCE DISCLOSED, THE MEDICAL STAFF MEMBER IS REMOVED FROM ANY DISCUSSION, DECISION-MAKING, AND/OR VOTE ON ANY RELATED ISSUE. FORM 990, PART VI, SECTION B, LINE 15 AT THE DIRECTION OF THE BOARD OF DIRECTORS, KDMC SET COMPENSATION FOR THE TEAM MEMBERS AND LEADERS USING LOCAL, REGIONAL AND NATIONAL SALARY INFORMATION PROVIDED THROUGH SURVEY DATA. THE PRIMARY OBJECTIVE OF KING'S DAUGHTERS COMPENSATION PHILOSOPHY IS TO HAVE COMPENSATION AND BENEFITS SET THAT REFLECT OTHER SIMILAR INDEPENDENT NOT FOR PROFIT HEALTHCARE SERVICES AS WELL AS THE WORK PERFORMANCE OF THE ORGANIZATION. MERCER, AN INDEPENDENT COMPENSATION EXPERT, PERIODICALLY PERFORMS A REVIEW OF EXECUTIVE COMPENSATION AND BENEFITS. SULLIVAN COTTER, AN INDEPENDENT COMPENSATION EXPERT, PROVIDES ANNUAL MARKET SURVEY DATA FOR PHYSICIAN COMPENSATION AND BENEFITS WHICH IS USED FOR DETERMINATION OF FAIR MARKET VALUE. FORM 990, PART VI, SECTION C, LINE 19 ON A QUARTERLY BASIS, THE FINANCIAL STATEMENTS ARE REPORTED TO THE MUNICIPAL SECURITIES RULEMAKING BOARD AND MADE AVAILABLE ON THEIR WEBSITE. GOVERNING DOCUMENTS AND THE CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: FORGIVENESS OF INTERCOMPANY PAYABLES 61,993. INCREASE IN INTERCOMPANY PAYABLE -1,057. ASHLAND HOSPITAL CORPORATION 2201 LEXINGTON AVE ASHLAND KY 41101 610444716 HEALTHCARE KY 501(C)(3) LINE 3 ROYAL BLUE HEALTH LLC 0 ASHLAND NURSING HOME CORPORATION 2500 STATE ROUTE 5 ASHLAND KY 41102 611386016 NURSING HOME KY 501(C)(3) LINE 10 ASHLAND HOSPITAL CORPORATION 0 KENTUCKY MEDICAL LOGISTICS INC 425 22ND STREET ASHLAND KY 41101 264736971 MEDICAL TRANSPORT KY 501(C)(3) LINE 10 ASHLAND HOSPITAL CORPORATION 0 KING'S DAUGHTERS HEALTH SYSTEM INC 2201 LEXINGTON AVE ASHLAND KY 41101 274553836 HEALTHCARE KY 501(C)(3) LINE 12B, II N/A 0 CHILD DEVELOPMENT CENTER CORPORATION 2201 LEXINGTON AVE ASHLAND KY 41101 010560598 DAYCARE KY 501(C)(3) LINE 10 ASHLAND HOSPITAL CORPORATION 0 KING'S DAUGHTERS MEDICAL SPECIALTIES INC 2201 LEXINGTON AVE ASHLAND KY 41101 264183569 PHYSICIANS KY 501(C)(3) LINE 10 ASHLAND HOSPITAL CORPORATION 0 KENTUCKY HEART INSTITUTE 2201 LEXINGTON AVE ASHLAND KY 41101 611255904 PHYSICIANS KY 501(C)(3) LINE 10 ASHLAND HOSPITAL CORPORATION 0 PORTSMOUTH HOSPITAL CORPORATION 1901 ARGONNE AVE PORTSMOUTH OH 45662 453215312 HEALTHCARE OH 501(C)(3) LINE 3 ROYAL BLUE HEALTH LLC 0 ROYAL BLUE HEALTH LLC 2201 LEXINGTON AVE ASHLAND KY 41101 862993817 HEALTHCARE KY 501(C)(3) LINE 12B, II N/A 0 KING'S DAUGHTERS HEALTH FOUNDATION INC 2201 LEXINGTON AVE ASHLAND KY 41101 611035701 FUNDRAISING KY 501(C)(3) LINE 12B, II N/A 0 ASHLAND MEDICAL PROPERTIES INC 2201 LEXINGTON AVE ASHLAND KY 41101 611079090 RENTALS KY N/A C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1